AngioDynamics: Discounted Sales Multiple With Real Growth Engines [Seeking Alpha]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Seeking Alpha
ANGO's Med Tech division now drives 47% of sales, with strong performance from Auryon, AlphaVac, AngioVac, and NanoKnife products. Gross margin improved to 55.3%, operating costs are under control, and management expects positive cash flow and raised guidance for FY 2026. Valuation is attractive, with ANGO's EV/Sales and P/S ratios well below sector averages, supporting significant upside if execution continues. Morsa Images/DigitalVision via Getty Images Thesis Last time I looked at AngioDynamics, Inc. (NASDAQ: ANGO ), I rated the stock a Buy My reasoning was around the fact that the company has a growing set of medical technology This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of ANGO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]Seeking Alpha
- AngioDynamics to Participate in the UBS Global Healthcare ConferenceBusiness Wire
- H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance [Yahoo! Finance]Yahoo! Finance
- Insider Spends US$112k Buying More Shares In AngioDynamics [Yahoo! Finance]Yahoo! Finance
- AngioDynamics' NanoKnife® System Named to TIME's 2025 Best Inventions List [Yahoo! Finance]Yahoo! Finance
ANGO
Earnings
- 10/2/25 - Beat
ANGO
Analyst Actions
- 10/3/25 - Canaccord Genuity
ANGO
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- 10/22/25 - Form 4
- ANGO's page on the SEC website